AU2048492A - Use of 1,4-dihydropyridines in diabetes - Google Patents

Use of 1,4-dihydropyridines in diabetes

Info

Publication number
AU2048492A
AU2048492A AU20484/92A AU2048492A AU2048492A AU 2048492 A AU2048492 A AU 2048492A AU 20484/92 A AU20484/92 A AU 20484/92A AU 2048492 A AU2048492 A AU 2048492A AU 2048492 A AU2048492 A AU 2048492A
Authority
AU
Australia
Prior art keywords
dihydropyridines
diabetes
nimodipine
medicament
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU20484/92A
Other versions
AU659177B2 (en
Inventor
Willem Hendrik Gispen
Jorg Traber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Troponwerke GmbH
Original Assignee
Troponwerke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke GmbH filed Critical Troponwerke GmbH
Publication of AU2048492A publication Critical patent/AU2048492A/en
Application granted granted Critical
Publication of AU659177B2 publication Critical patent/AU659177B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the use of 1,4-dihydropyridines with a calcium-antagonistic action, especially of nimodipine, for the preparation of a medicament for controlling damage to peripheral nerves caused by diabetes.
AU20484/92A 1991-07-30 1992-07-22 Use of 1,4-dihydropyridines in diabetes Ceased AU659177B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4125116A DE4125116A1 (en) 1991-07-30 1991-07-30 USE OF 1,4-DIHYDROPYRIDINE IN DIABETES
DE4125116 1991-07-30

Publications (2)

Publication Number Publication Date
AU2048492A true AU2048492A (en) 1993-02-04
AU659177B2 AU659177B2 (en) 1995-05-11

Family

ID=6437256

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20484/92A Ceased AU659177B2 (en) 1991-07-30 1992-07-22 Use of 1,4-dihydropyridines in diabetes

Country Status (19)

Country Link
EP (1) EP0525537B1 (en)
JP (1) JP3381198B2 (en)
KR (1) KR930001908A (en)
AT (1) ATE111732T1 (en)
AU (1) AU659177B2 (en)
CA (1) CA2074709A1 (en)
CZ (1) CZ281712B6 (en)
DE (2) DE4125116A1 (en)
DK (1) DK0525537T3 (en)
ES (1) ES2059181T3 (en)
HU (1) HU208632B (en)
IE (1) IE65109B1 (en)
IL (1) IL102648A (en)
MX (1) MX9204423A (en)
NO (1) NO300253B1 (en)
RU (1) RU2043102C1 (en)
SK (1) SK238692A3 (en)
TW (1) TW202388B (en)
ZA (1) ZA925686B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863360A (en) * 1988-01-15 1989-09-05 Rogers Industrial Products Bag control mechanism for tire press

Also Published As

Publication number Publication date
CZ238692A3 (en) 1994-01-19
DK0525537T3 (en) 1995-02-20
HUT63330A (en) 1993-08-30
NO922795L (en) 1993-02-01
ATE111732T1 (en) 1994-10-15
KR930001908A (en) 1993-02-22
DE59200530D1 (en) 1994-10-27
IE65109B1 (en) 1995-10-04
IE922467A1 (en) 1993-02-10
NO300253B1 (en) 1997-05-05
NO922795D0 (en) 1992-07-15
DE4125116A1 (en) 1993-02-04
HU9202484D0 (en) 1992-10-28
CA2074709A1 (en) 1993-01-31
RU2043102C1 (en) 1995-09-10
IL102648A0 (en) 1993-01-14
ES2059181T3 (en) 1994-11-01
HU208632B (en) 1993-12-28
ZA925686B (en) 1993-04-28
EP0525537A1 (en) 1993-02-03
MX9204423A (en) 1993-01-01
SK238692A3 (en) 1995-11-08
CZ281712B6 (en) 1996-12-11
EP0525537B1 (en) 1994-09-21
TW202388B (en) 1993-03-21
JP3381198B2 (en) 2003-02-24
JPH06157314A (en) 1994-06-03
IL102648A (en) 1997-03-18
AU659177B2 (en) 1995-05-11

Similar Documents

Publication Publication Date Title
AU1760988A (en) Enhancers for the transdermal flux of certain 1,4-dihydropyridine derivatives
EP1607387A3 (en) 3,4,4-trisubstituted piperidine derivatives and their use as opioid antagonists
NZ227131A (en) Compositions for improving cognitive function by administering 1,2-oxazole derivatives
AU644051B2 (en) Piperidine derivatives
AU633754B2 (en) Composition for eye drops
KR900700569A (en) 2,3-difluorobenzene derivative
AU2868789A (en) 1,4-disubstituted-piperidinyl compounds
AU6853187A (en) 1,4-benzoxazine derivatives
AU3548993A (en) Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
AU1626488A (en) 1,4-dihydropyridine enantiomers
AU7408891A (en) Phenoxyalkanol as a stabilizer for isothiazolones
AU5486490A (en) Substituted 2,4 - diamino-quinazoline derivatives
AU657397B2 (en) 3,4-diaryl-(5H)-furan-2-one based compounds with fungicidal activity
AU2048492A (en) Use of 1,4-dihydropyridines in diabetes
DE69426021D1 (en) Xamonelin tartrate
GR3007079T3 (en)
AU6984987A (en) Substituted 1,4-dihydropyridine ester derivatives
AU3668989A (en) 1,7-dioxy-naphthalene derivatives
AU3703093A (en) Monoquaternary 2,16-bispiperidinylandrostane derivatives
AU6506594A (en) 3-phenyl-1,2,5,6-tetrahydropyridine derivatives as sedatives
AU2857589A (en) Biocidal 4,5-dichloro-1,2-dithiol-3-one composition
AU2823089A (en) 2,4- diaminoquinazoline derivatives
AU5326286A (en) 2,6-dialkyl-4-aryl-1,4-dihydropyridine-3,5 dicarboxylate derivatives
AU1973888A (en) Novel 2-(substituted imino)-1,3,4-dihydrothiazoles
AU7128587A (en) 1,4-dihydropyridines